Any current/future new fundraising through debt or equity?

No explicit mention of any new fundraising through debt or equity in the transcript. The company maintains a robust balance sheet with a cash position of INR 579 crores as of December 31, 2025. Capital expenditures and merger & acquisition plans are expected to be funded through current cash and anticipated internal accruals. The company states it is well-positioned to complete all planned capital expenditures using internal resources without the need for external fundraising.

Any current/future capex/capital investment/strategic investment?

The company invested INR 57 crores in capex during the quarter to expand and enhance services at existing and upcoming hospitals. Significant capital expenditure planned for evolving into a “digital front-door” hospital model, enhancing digital user experience with revamped website, patient app, doctor interfaces, and full EMR ecosystem. Expansion planned with additional beds at Visakhapatnam (50 beds) and Guwahati in early next financial year. Ongoing investments in hospital projects with a pipeline of bed additions expected over the next 18-24 months. Focus on building digital ecosystem and

Future growth expectations in sales/revenue/volumes?

The company targets an 18% revenue CAGR over the medium term, with a four-year CAGR of about 17-18%. (Page 17) Revenue growth for the quarter was 12% YoY; 9% for the first 9 months of the financial year. (Page 6) Organic growth is currently mid-single digits; recovery expected in FY27 and FY28. (Page 17) Expansion plans include operationalizing more beds at Guwahati soon and scaling mature clusters like Andhra Pradesh, Chennai, and Bangalore. (Pages 11, 17, 19) Digital initiatives and marketing ramp-up are expected to boost sales over the next 1-2 years. (Page 19) New hospital units

Future growth expectations in earnings/operating earnings/profits/EPS?

Rainbow Children's Medicare targets a medium-term revenue CAGR of around 17-18%, with historical delivery in this range. EBITDA margins aim to stabilize around 24%-25% long term, maintaining strong operational profitability. PAT growth has been steady, with a 7.2% increase in the latest quarter and 8.3% over the first nine months, indicating continued profit growth. The company expects recovery in organic growth to pick up from FY27 and FY28, aligning with leadership changes and strategic initiatives. ARPP (Average Revenue Per Patient) is projected to grow at 5%-7% CAGR over the long term, sup

IN US

Sale is live|00:00:00left today

Rainbow Childrens Medicare LtdQ4 FY27Healthcare Services

Rainbow Childrens Medicare Ltd Q4 FY27 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹1,410P/E: 49.4Market Cap: ₹12.7K CrSector: Healthcare Services

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

N/A

Order

N/A

Capex

Yes

1 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 3

→The company targets an 18% revenue CAGR over the medium term, with a four-year CAGR of about 17-18%. (Page 17)
→Revenue growth for the quarter was 12% YoY; 9% for the first 9 months of the financial year. (Page 6)
→Organic growth is currently mid-single digits; recovery expected in FY27 and FY28. (Page 17)
→Expansion plans include operationalizing more beds at Guwahati soon and scaling mature clusters like Andhra Pradesh, Chennai, and Bangalore. (Pages 11, 17, 19)
→Digital initiatives and marketing ramp-up are expected to boost sales over the next 1-2 years. (Page 19)
→New hospital units generally take 12-15 months to break even and contribute positively to revenues thereafter. (Page 11)
→Focus is on increasing occupancy from ~47% towards 55%-60%, which will support better margins and growth. (Pages 6, 18)

Margin guidance

Category 3

→Rainbow Children's Medicare targets a medium-term revenue CAGR of around 17-18%, with historical delivery in this range.
→EBITDA margins aim to stabilize around 24%-25% long term, maintaining strong operational profitability.
→PAT growth has been steady, with a 7.2% increase in the latest quarter and 8.3% over the first nine months, indicating continued profit growth.
→The company expects recovery in organic growth to pick up from FY27 and FY28, aligning with leadership changes and strategic initiatives.
→ARPP (Average Revenue Per Patient) is projected to grow at 5%-7% CAGR over the long term, supporting revenue and earnings growth.
→Focused capacity utilization improvements (targeting 55%-60% occupancy) and digital initiatives are expected to drive volumetric and margin expansion.
→New hospital ramp-ups (e.g., Rajahmundry breakeven from next year) will contribute to earnings growth over the medium term.

3 more insights locked — sign up free to unlock

Fundraise plans

→No explicit mention of any new fundraising through debt or equity in the transcript.
→The company maintains a robust balance sheet with a cash position of INR 579 crores as of December 31, 2025.
→Capital expenditures and merger & acquisition plans are expected to be funded through current cash and anticipated internal accruals.
→The company states it is well-positioned to complete all planned capital expenditures using internal resources without the need for external fundraising.

Order book

The transcript does not explicitly mention the current or expected order book or pending orders for Rainbow Children's Medicare Limited. However, some related points on capacity expansion and projects include: - Over the last two years, approximately 780 beds have been added, indicating significant capacity expansion. - The next phase of bed additions is expected over the next 18 to 24 months, providing a 1.5-year runway for operational execution. - Some project delays have occurred, ranging from one to two quarters historically, but recently some projects faced 9-12 month delays. - Delays in Coimbatore were due to re-sanctioning and caused a 6-month delay. - Execution timelines are becoming more predictable as processes improve. - Capacity additions will focus on operational execution, occupancy growth, and optimizing performance from recently added capacity. No specific figures or confirmed order book details are provided in the transcript.

Capex plans

Yes

→The company invested INR 57 crores in capex during the quarter to expand and enhance services at existing and upcoming hospitals.
→Significant capital expenditure planned for evolving into a “digital front-door” hospital model, enhancing digital user experience with revamped website, patient app, doctor interfaces, and full EMR ecosystem.
→Expansion planned with additional beds at Visakhapatnam (50 beds) and Guwahati in early next financial year.
→Ongoing investments in hospital projects with a pipeline of bed additions expected over the next 18-24 months.
→Focus on building digital ecosystem and marketing initiatives to drive volume and occupancy growth.
→Plans to operationalize new specialty services like liver transplants and pediatric subspecialties across different centers over the next 16 to 18 months.
→Internal resources (cash reserves and accruals) will fund upcoming capital expenditures, including merger and acquisition activities.

How does Rainbow Childrens Medicare Ltd rank vs peers in Healthcare Services?

Pro feature

1Rainbow Childrens Medicare Ltd

Rev 3Mar 3

See full Healthcare Services sector rankings

Want more stocks like Rainbow Childrens Medicare Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio